Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 43 (4), 447-457
- https://doi.org/10.1016/j.semarthrit.2013.07.011
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune DiseasesJama-Journal Of The American Medical Association, 2011
- The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsAnnals Of The Rheumatic Diseases, 2011
- TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid ArthritisMedicine, 2011
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology, 2010
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals Of The Rheumatic Diseases, 2010
- A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overviewCMAJ : Canadian Medical Association Journal, 2009
- From Randomized Controlled Trials to Observational StudiesAmerican Journal Of Medicine, 2009
- Observational Research, Randomised Trials, and Two Views of Medical SciencePLoS Medicine, 2008
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995